Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Development of kefir-based probiotic beverages with DNA protection and antioxidant activities using soybean hydrolyzed extract, colostrum and honey
Key Leaders: Alex Dresner, Co-Founder and CEO Number of Employees: 100-250 Stage: Series C Financial Snapshot: $134.3 million in funding so far Notable Investors: GV (formerly Google Ventures), Brooklyn Bridge Ventures, Teamworthy Ventures, and Casdin Capital Key Products: Imagen Technologies developed and received FDA clearance for its AI imaging software tools, which are part of its Diagnostics-as-a-Service (DaaS) platform
Our experienced medical providers carefully evaluate each patients medical history, treatment goals, preferences, and potential side effects when recommending the most suitable GLP-1 receptor agonist
In vitro cellular uptake and insulin secretion studies on INS-1E cells of exendin-4-loaded self-nanoemulsifying drug delivery systems
The majority of patients were White (78%) and 57.7% were male
Over time, that reduction in caloric intake leads to meaningful, sustained weight loss especially when paired with a reduced-calorie diet and increased physical activity
US$ 28.09
US$ 27.53
US$ 24.07
US$ 24.07
US$ 29.13
